| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |